| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 19,906 | 19,564 | 17,508 | 20,157 |
| Cost of goods sold | 2,709 | 2,977 | 2,414 | 3,250 |
| Gross profit | 17,197 | 16,587 | 15,094 | 16,907 |
| Research and development | 3,352 | 4,387 | 4,430 | 4,746 |
| Selling, general and administrative | 21,750 | 23,867 | 24,523 | 23,390 |
| Total operating expenses | 25,102 | 28,254 | 28,953 | 28,136 |
| Loss from operations | -7,905 | -11,667 | -13,859 | -11,229 |
| Investment income | 965 | 1,026 | 1,148 | 1,454 |
| Interest expense | 1,306 | 1,284 | 1,263 | 1,151 |
| Loss on debt extinguishment | 0 | 0 | - | - |
| Other (expense) income, net | -2 | 24 | -139 | 26 |
| Loss before income taxes | -8,248 | -11,901 | -14,113 | -10,900 |
| Provision for income taxes | -79 | 40 | 41 | 166 |
| Net loss and comprehensive loss | -8,169 | -11,941 | -14,154 | -11,066 |
| Net loss per share attributable to common stockholders-basic | -0.16 | -0.23 | -0.28 | -0.22 |
| Net loss per share attributable to common stockholders-diluted | -0.16 | -0.23 | -0.28 | -0.22 |
| Weighted-average shares of common stock outstanding-basic | 52,377,805 | 51,821,773 | 51,290,665 | 50,340,603 |
| Weighted-average shares of common stock outstanding-diluted | 52,377,805 | 51,821,773 | 51,290,665 | 50,340,603 |
Sight Sciences, Inc. (SGHT)
Sight Sciences, Inc. (SGHT)